Correlation Engine 2.0
Clear Search sequence regions

  • child (2)
  • children (1)
  • female (1)
  • help (1)
  • human (3)
  • orphans (1)
  • pregnancy (2)
  • research (4)
  • therapeutics research (4)
  • Sizes of these terms reflect their relevance to your search.

    Maternal and pediatric populations have historically been considered "therapeutic orphans" due to their limited inclusion in clinical trials. Physiologic changes during pregnancy and lactation and growth and maturation of children alter pharmacokinetics (PK) and pharmacodynamics (PD) of drugs. Precision therapy in these populations requires knowledge of these effects. Efforts to enhance maternal and pediatric participation in clinical studies have increased over the past few decades. However, studies supporting precision therapeutics in these populations are often small and, in isolation, may have limited impact. Integration of data from various studies, for example through physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling or bioinformatics approaches, can augment the value of data from these studies, and help identify gaps in understanding. To catalyze research in maternal and pediatric precision therapeutics, the Obstetric and Pediatric Pharmacology and Therapeutics Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) established the Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub. Herein, we provide an overview of the status of maternal-pediatric therapeutics research and introduce the Indiana University-Ohio State University MPRINT Hub Data, Model, Knowledge and Research Coordination Center (DMKRCC), which aims to facilitate research in maternal and pediatric precision therapeutics through the integration and assessment of existing knowledge, supporting pharmacometrics and clinical trials design, development of new real-world evidence resources, educational initiatives, and building collaborations among public and private partners, including other NICHD-funded networks. By fostering use of existing data and resources, the DMKRCC will identify critical gaps in knowledge and support efforts to overcome these gaps to enhance maternal-pediatric precision therapeutics. © 2023 The Authors. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy published by Wiley Periodicals LLC on behalf of Pharmacotherapy Publications, Inc.


    Sara K Quinney, Robert R Bies, Shaun J Grannis, Christopher W Bartlett, Eneida Mendonca, Colin M Rogerson, Carl H Backes, Dhaval K Shah, Emma M Tillman, Maged M Costantine, Blessed W Aruldhas, Reva Allam, Amelia Grant, Mohammad Yaseen Abbasi, Murugesh Kandasamy, Yong Zang, Lei Wang, Aditi Shendre, Lang Li. The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal-pediatric therapeutics research through data integration and pharmacometrics. Pharmacotherapy. 2023 May;43(5):391-402

    Expand section icon Mesh Tags

    PMID: 36625779

    View Full Text